Pioglitazone Incretin Study

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Pioglitazone

Starting dose at 15 mg for two weeks, then titrated up to 45 mg in the subsequent 2 weeks.

DRUG

Placebo

placebo

Trial Locations (1)

05403

University of Vermont, South Burlington

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

University of Vermont

OTHER